Crown Bioscience, Inc.
Records under this name other than the patents Crown Bioscience, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 7 of 7 · Back to Crown Bioscience, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,359,338 | Cyclopropanecarboxamido-substitute aromatic compounds as anti-tumor agents Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,030,243 | Process for making camptothecin derivatives Term ended Term ended Oct 28, 2024 · From the USPTO record | Term ended | Term ended Oct 28, 2024 | From the USPTO record |
| US 6,723,849 | Process for making camptothecin derivatives Term ended Term ended Jul 25, 2023 · From the USPTO record | Term ended | Term ended Jul 25, 2023 | From the USPTO record |
| US 7,687,487 | Camptothecin-analog with a novel, “flipped” lactone-stable, E-ring and methods for making and using same Lapsed on the fee record Ended Mar 30, 2022 · From the USPTO record | Lapsed on the fee record | Ended Mar 30, 2022 | From the USPTO record |
| US 7,687,496 | C7-substituted camptothecin analogs Lapsed on the fee record Ended Mar 30, 2022 · From the USPTO record | Lapsed on the fee record | Ended Mar 30, 2022 | From the USPTO record |
| US 7,687,497 | C10-substituted camptothecin analogs Lapsed on the fee record Ended Mar 30, 2022 · From the USPTO record | Lapsed on the fee record | Ended Mar 30, 2022 | From the USPTO record |
| US 8,569,265 | Deuterated analogs of (4S)-4-ethyl-4-hydroxy-11-[2- (trimethylsilyl)ethyl]-1H-pyrano[3′, 4′:6,7] indolizino [1,2-b]quinoline-3,14(4H, 12H)-dione and methods of use thereof Lapsed on the fee record Ended Oct 29, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 29, 2021 | From the USPTO record |